325 related articles for article (PubMed ID: 24950272)
1. Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysis.
Fayanju OM; Stoll CR; Fowler S; Colditz GA; Margenthaler JA
Ann Surg; 2014 Dec; 260(6):1000-10. PubMed ID: 24950272
[TBL] [Abstract][Full Text] [Related]
2. Contralateral prophylactic mastectomy in a rural population: A single-institution experience.
Clegg DJ; Whiteaker EN; Salomon BJ; Gee KN; Porter CG; Mazonas TW; Heidel RE; Brooks AJ; Bell JL; Boukovalas S; Lloyd JM
Surg Open Sci; 2024 Mar; 18():70-77. PubMed ID: 38435489
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
4. Contralateral breast cancer and tumor recurrence in BRCA1/2 carriers and non-carriers at a high risk of hereditary breast cancer after bilateral mastectomy.
Allué Cabañuz M; Domingo Bretón M; Chóliz Ezquerro J; Arribas Del Amo MD; Güemes Sánchez AT
Cir Esp (Engl Ed); 2020 Dec; 98(10):612-617. PubMed ID: 32505558
[TBL] [Abstract][Full Text] [Related]
5. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
6. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
7. Physician Knowledge of Breast Cancer Recurrence and Contralateral Breast Cancer Risk is Associated with Increased Recommendations for Contralateral Prophylactic Mastectomy: a Survey of Physicians at NAPBC-Accredited Centers.
Kantor O; Chang C; Bleicher RJ; Moran M; Connolly JL; Kurtzman SH; Yao K;
Ann Surg Oncol; 2019 Oct; 26(10):3080-3088. PubMed ID: 31342369
[TBL] [Abstract][Full Text] [Related]
8. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.
Portschy PR; Kuntz KM; Tuttle TM
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031308
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine NE; Wallace J
Cochrane Database Syst Rev; 2010 Nov; (11):CD002748. PubMed ID: 21069671
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
11. Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
ElSherif A; Armanyous S; Gentle CK; Al-Hilli Z; Valente SA
Am J Surg; 2022 Mar; 223(3):533-537. PubMed ID: 34924172
[TBL] [Abstract][Full Text] [Related]
12. Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.
Wang F; Amara D; Peled AW; Sbitany H; Foster RD; Ewing CA; Alvarado M; Esserman LJ
Ann Surg Oncol; 2015 Oct; 22(10):3338-45. PubMed ID: 26215194
[TBL] [Abstract][Full Text] [Related]
13. EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
Schmidt MK; Kelly JE; Brédart A; Cameron DA; de Boniface J; Easton DF; Offersen BV; Poulakaki F; Rubio IT; Sardanelli F; Schmutzler R; Spanic T; Weigelt B; Rutgers EJT
Eur J Cancer; 2023 Mar; 181():79-91. PubMed ID: 36641897
[TBL] [Abstract][Full Text] [Related]
14. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
17. Contralateral Prophylactic Mastectomy among Women with Pathogenic Variants in
Makhnoon S; Gutierrez Barrera AM; Bassett R; Afrough A; Bedrosian I; Arun BK
Breast J; 2022; 2022():1447545. PubMed ID: 36685664
[TBL] [Abstract][Full Text] [Related]
18. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
19. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
[TBL] [Abstract][Full Text] [Related]
20. Tools for Contralateral Prophylactic Mastectomy Decision Making.
Gail MH; Jatoi I
J Clin Oncol; 2022 Nov; 40(31):3653-3659. PubMed ID: 35759730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
